Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.21% |
| 2 | Technology | 12.9% |
| 3 | Consumer Discretionary | 10.45% |
| 4 | Financials | 8.47% |
| 5 | Industrials | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Helix Energy Solutions
HLX
$1.4B
| $6.49M | 0.01% |
673,429
+242,202
| +56% | +$2.1M |
|
1702
V2X
VVX
$2.83B
| $6.48M | 0.01% |
126,400
-2,200
| -2% | -$106K |
|
1703
Comscore
SCOR
$106M
| $6.47M | 0.01% |
65,532
+10,555
| +19% | +$722K |
|
1704
Diana Shipping
DSX
$302M
| $6.47M | 0.01% |
2,977,432
+363,270
| +14% | +$879K |
|
1705
American Vanguard Corp
AVD
$68.4M
| $6.47M | 0.01% |
332,469
-155,631
| -32% | -$2.45M |
|
1706
Landstar System
LSTR
$5.93B
| $6.47M | 0.01% |
+56,840
| New | +$6.42M |
|
1707
Woodward
WWD
$21.5B
| $6.46M | 0.01% |
54,584
-56,200
| -51% | -$6.34M |
|
|
AVDL
1708
DELISTED
Avadel Pharmaceuticals
AVDL
| $6.45M | 0.01% |
854,006
+32,000
| +4% | +$169K |
|
1709
PVH
PVH
$4B
| $6.44M | 0.01% |
61,275
-463,400
| -88% | -$44.2M |
|
|
STFC
1710
DELISTED
State Auto Financial Corp
STFC
| $6.44M | ﹤0.01% |
207,600
-51,168
| -20% | -$1.65M |
|
1711
Liberty Latin America Class A
LILA
$1.64B
| $6.43M | ﹤0.01% |
520,545
+54,698
| +12% | +$636K |
|
1712
Sally Beauty Holdings
SBH
$1.43B
| $6.43M | ﹤0.01% |
+352,300
| New | +$6.12M |
|
1713
Crane NXT
CXT
$2.99B
| $6.43M | ﹤0.01% |
214,198
-29,941
| -12% | -$853K |
|
1714
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.75B
| $6.41M | ﹤0.01% |
64,300
-12,555
| -16% | -$1.24M |
|
1715
Kamada
KMDA
$412M
| $6.41M | ﹤0.01% |
937,829
+107,605
| +13% | +$655K |
|
1716
Natera
NTRA
$38.3B
| $6.4M | ﹤0.01% |
+190,000
| New | +$7M |
|
|
SNCR
1717
DELISTED
Synchronoss Technologies
SNCR
| $6.4M | ﹤0.01% |
149,666
+4,766
| +3% | +$212K |
|
1718
John Wiley & Sons Class A
WLY
$2.65B
| $6.39M | ﹤0.01% |
131,800
-110,300
| -46% | -$5.13M |
|
1719
Mistras Group
MG
$484M
| $6.39M | ﹤0.01% |
447,540
-102,100
| -19% | -$1.44M |
|
1720
Rigel Pharmaceuticals
RIGL
$681M
| $6.37M | ﹤0.01% |
297,694
+108,230
| +57% | +$2.23M |
|
|
FFG
1721
DELISTED
FBL Financial Group
FFG
| $6.35M | ﹤0.01% |
107,700
+13,100
| +14% | +$754K |
|
|
RPT
1722
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $6.33M | ﹤0.01% |
421,100
+286,100
| +212% | +$4.09M |
|
1723
SmartFinancial
SMBK
$896M
| $6.32M | ﹤0.01% |
267,377
+72,503
| +37% | +$1.6M |
|
1724
Southern Missouri Bancorp
SMBC
$852M
| $6.32M | ﹤0.01% |
164,634
+3,800
| +2% | +$141K |
|
|
TA
1725
DELISTED
TravelCenters of America LLC
TA
| $6.29M | ﹤0.01% |
366,799
| – | – |
|
Similar funds
Renaissance Technologies's Q4 2019 Portfolio in Review
As of Q4 2019, Renaissance Technologies held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Renaissance Technologies's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Renaissance Technologies added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Renaissance Technologies's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Renaissance Technologies fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Renaissance Technologies's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Renaissance Technologies opened 518 new positions and closed 443 in Q4 2019.
- Renaissance Technologies's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.